Blood Res.  2017 Sep;52(3):219-221. 10.5045/br.2017.52.3.219.

A case of synchronous multiple myeloma and chronic myeloid leukemia

• Lee JY
• Lee SM
• Yoon HK
• Kim KH
• Choi MY
• Lee WS

• KMID: 2390986
• DOI: http://doi.org/10.5045/br.2017.52.3.219

Abstract

No abstract available.

MeSH Terms

Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Multiple Myeloma*

Figure

• 

  Fig. 1 Biopsy of the right pleural soft-tissue mass. (A) Infiltration of plasma cells (H&E staining, ×400). (B) Positive for immunohistochemical staining of CD138 (×100).

• 

  Fig. 2 Bone marrow biopsy and aspiration at diagnosis. (A) Bone marrow biopsy shows increased cellularity up to 90% (H&E, ×100). (B) Bone marrow aspiration shows myeloid hyperplasia with increased eosinophils (Wright-Giemsa staining, ×1,000). (C) Bone marrow aspiration shows increased mature forms of plasma cells (Wright-Giemsa staining, ×1,000).

Reference

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65:5–29. PMID: 25559415.

2. Hong J, Lee JH. Recent advances in multiple myeloma: a Korean perspective. Korean J Intern Med. 2016; 31:820–834. PMID: 27604794.

3. Au WY, Caguioa PB, Chuah C, et al. Chronic myeloid leukemia in Asia. Int J Hematol. 2009; 89:14–23. PMID: 19101781.

4. Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol. 2005; 23:3412–3420. PMID: 15809451.

5. Sokal JE, Cox EB, Baccarani M, et al. Prognostic discrimination in “good-risk” chronic granulocytic leukemia. Blood. 1984; 63:789–799. PMID: 6584184.

6. Ide M, Kuwahara N, Matsuishi E, Kimura S, Gondo H. Uncommon case of chronic myeloid leukemia with multiple myeloma. Int J Hematol. 2010; 91:699–704. PMID: 20352382.

7. Alsidawi S, Ghose A, Qualtieri J, Radhakrishnan N. A case of multiple myeloma with metachronous chronic myeloid leukemia treated successfully with bortezomib, dexamethasone, and dasatinib. Case Rep Oncol Med. 2014; 2014:962526. PMID: 25544920.

8. Offiah C, Quinn JP, Thornton P, Murphy PT. Co-existing chronic myeloid leukaemia and multiple myeloma: rapid response to lenalidomide during imatinib treatment. Int J Hematol. 2012; 95:451–452. PMID: 22426625.

9. Monroy RH, Vargas-Viveros P, Ceballos EC, Velazquez JC, Munos SC. Imatinib (IM) plus thalidomide (Thali), a effective combination for the treatment of chronic myeloid leukemia (CML) Philadelphia chromosomepositive (Ph +) in IM-resistant disease. Report of 14 new cases from a single center in Mexico. Blood. 2013; 122:5172.